Many of us remember learning about the mitochondria, the powerhouse of the cell, in school. But few of us learned what happens when the cell’s powerhouse no longer works properly: Mitochondria dysfunction has been tied to many medical conditions, including heart disease, stroke, diabetes, Parkinson’s, and Alzheimer’s. Alexander Schueller and his team develop a new approach to reinvigorate the cell energy metabolism by pioneering Therapeutic Mitochondria Transplantation. In this novel treatment approach, mitochondria are transferred directly into compromised cells, where they rescue and contribute to the cells’ energy metabolism. Learn more about Alexander’s expectations for the Venture Leaders Biotech experience, and find out more about the helpful advice, important lessons, and rewarding aspects that shape his entrepreneurial career.
Switzerland boasts one of the world’s most renowned and innovative biotech industries. To do justice to this powerful position, Swiss biotech startups now have their own Venture Leaders program: During their roadshow, the Venture Leaders Biotech will meet international investors and industry leaders and access industry-specific expertise and networks to grow their companies. For the next few weeks, we shine the spotlight on the 10 Venture Leaders Biotech 2021 and introduce you to the inaugural graduates of the program. To learn more about the startups, we asked each entrepreneur to complete a short profile and choose at least six questions from a questionnaire about their personal and professional life.
Name: Alexander Schueller
Location: Matzingen (TG)
Nationality: German
Graduated from: RWTH Aachen University
Your job title: Founder and CEO of cellvie
Number of employees: 6
First touchpoint with Venturelab: In 2021, for the Venture Leaders Medtech